About the Authors
- Micha Loebermann
-
* E-mail: micha.loebermann@uni-rostock.de
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Ulrich Voss
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Seetha Meyer
-
Affiliation Novartis Vaccines and Diagnostics GmbH, Marburg, Germany
- Dietrich Bosse
-
Affiliation Novartis Vaccines and Diagnostics GmbH, Marburg, Germany
- Carlos Fritzsche
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Sebastian Klammt
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Silvius Frimmel
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Diana Riebold
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
- Emil C. Reisinger
-
Affiliation Department of Tropical Medicine, Infectious Diseases and Nephrology, University of Rostock, Rostock, Germany
Competing Interests
This study was funded by Novartis Vaccines, the employer of SM and DB. There are no patents, products in development or marketed products other than those described in the manuscript. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: ML SM DB ECR. Performed the experiments: ML UV CF SK SF DR ECR. Analyzed the data: ML UV DB ECR. Wrote the paper: ML UV ECR.